Clinical Trial Update: Intermittent Hypoxia and Caffeine in Infants Born Preterm [Phase 2]

View source ↗

Summary

Phase 2 trial update assessing intermittent hypoxia and caffeine in infants born preterm has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intermittent Hypoxia

Drugs mentioned

• Caffeine (caffeine)

Snippet

Sponsor: Children's National Research Institute | Conditions: Intermittent Hypoxia | Phase 2 | Status: COMPLETED